Advisory Board Member
Thomas Harding Ph.D is the Senior Vice President of Preclinical Research and Translational Medicine at Clovis Oncology. He has been greatly involved in the development and clinical application of PARP-Inhibitors.Tom did his undergraduate, post-graduate and post doc studies at University of Bristol in the UK before coming to the US. Outside the lab, he spends time pursuing his two boys around the go-kart track … but only on special occasions!